Teladoc Health Inc. ($TDOC) Stock Forecast: Down 9.2% Today

What is Teladoc Health Inc.?

Teladoc Health Inc. (TDOC) is a major player in the telemedicine industry, offering online doctor consultation services and digital health solutions. The company is part of a growing market fueled by technological advancements and the increasing demand for remote healthcare services.

Why is Teladoc Health Inc. going down?

TDOC stock is down 9.2% on Feb 11, 2026 16:17

• Today's decline in TDOC's stock price could be attributed to profit-taking by investors following a period of increased bullish activity in the options market.
• Concerns about Teladoc's financial health, including negative ROE and financial distress indicators, may have contributed to the stock's downward pressure despite positive long-term growth prospects for the telemedicine industry.
• The market response may be tied to valuation metrics indicating that TDOC's stock is currently trading near historical lows for its price-to-sales and price-to-book ratios, prompting questions about its current valuation and potential future growth.
• Despite the overall positive outlook for the telehealth market and the innovation and growth driven by key players, individual company performance and financial metrics like those of Teladoc can still impact short-term stock movements.

TDOC Price Chart

TDOC Technical Analysis

TDOC News

Telemedicine Market to Reach US$ 488.89 Billion by 2033 at 16.8% CAGR | North America Leads with 39% Share | Key Players Include Teladoc Health, Philips, GE HealthCare, Siemens Healthineers, American Well

The global telemedicine market is projected to grow significantly from US$ 129.70 billion in 2024 to US$ 488.89 billion by 2033, exhibiting a CAGR of 16.8%. This growth is fueled by increasing demand for remote healthcare, technological advancements, and supportive government policies. North America currently leads the market with a 39% share, while key players include Teladoc Health, Philips, GE HealthCare, Siemens Healthineers, and American Well.

https://www.openpr.com/news/4385979/telemedicine-market-to-reach-us-488-89-billion-by-2033-at-16-8

Digital Health Market to Reach US$ 1,907.21 Billion by 2033,

The global Digital Health Market is projected to grow from US$ 361.65 billion in 2024 to US$ 1,907.21 billion by 2033, demonstrating a CAGR of 20.6% during the forecast period. This growth is primarily driven by increasing adoption of digital healthcare solutions for improved patient outcomes, accessibility, and operational efficiency, although privacy and data security concerns remain a significant restraint. Key players like Philips, Medtronic, and Apple are contributing to market expansion through innovations in telehealth, remote monitoring, and AI-driven diagnostics.

https://www.openpr.com/news/4384717/digital-health-market-to-reach-us-1-907-21-billion-by-2033

Online Doctor Consultation Market Set for Explosive Growth

The Global Online Doctor Consultation Market is projected to experience explosive growth, reaching US$ 47.29 billion by 2033 from US$ 12.05 billion in 2024, driven by increased demand for convenient healthcare, digital health adoption, and technological advancements. North America currently holds the largest market share, while the Asia Pacific region is expected to show the fastest growth. Key players like Teladoc Health, PlushCare, and American Well are innovating with AI-enhanced platforms, wearable integrations, and expanded virtual care services to capture market opportunities despite challenges related to data privacy and the digital divide.

https://www.openpr.com/news/4383905/online-doctor-consultation-market-set-for-explosive-growth

Teladoc (TDOC) Sees Increased Bullish Activity in Options Market

Teladoc (TDOC) is experiencing significant bullish activity in its options market, with a notable volume of call options traded and a low Put/Call Ratio. Despite this, the company's financial health shows challenges, including a negative ROE and a Z-Score indicating financial distress. Valuation metrics suggest the stock may be undervalued, trading near historical lows for its P/S and P/B ratios.

https://www.gurufocus.com/news/8599088/teladoc-tdoc-sees-increased-bullish-activity-in-options-market

United States Telehealth Solutions Market to Grow at 32.1% CAGR

The United States Telehealth Solutions Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 32.1% between 2024 and 2031, with North America being the largest market. Key players like Teladoc Health Inc., American Well, and MDLIVE Inc. are driving innovations like AI-powered platforms and remote monitoring. The market's growth is fueled by technological advancements, increased adoption due to the COVID-19 pandemic, and the rising demand for cost-effective, accessible healthcare solutions, despite challenges such as healthcare fraud and behavioral adoption barriers.

https://www.openpr.com/news/4382334/united-states-telehealth-solutions-market-to-grow-at-32-1-cagr

Trending Today

Wingstop Inc. ($WING) Stock Forecast: Down 5.4% Today

Cleveland-Cliffs Inc. ($CLF) Stock Forecast: Down 6.2% Today

Cognex Corporation ($CGNX) Stock Forecast: Up 33.1% Today

Lincoln National Corporation ($LNC) Stock Forecast: Up 5.6% Today

Lithia Motors Inc. ($LAD) Stock Forecast: Down 5.6% Today

Unity Software ($U) Stock Forecast: Up 5.4% Today

Alexandria Real Estate Equities Inc. ($ARE) Stock Forecast: Down 5.7% Today

Boston Properties Inc. ($BXP) Stock Forecast: Down 9.5% Today

Baxter International Inc. ($BAX) Stock Forecast: Down 12.7% Today

WESCO International, Inc. ($WCC) Stock Forecast: Up 5.3% Today

Teladoc Health Inc. Price History

15.00.2026 - TDOC Stock was down 6.1%

• Despite recent upgrades to its 24/7 Care service and virtual urgent care expansion, Teladoc Health's stock faced bearish movement today.
• The market's negative reaction may stem from concerns about the company's share price weakness and perceived undervaluation, marked by an estimated fair value of US$9.13.
• While unveiling new treatment capabilities and enhancing patient care, Teladoc Health faces investor caution regarding churn management and market competition.
• The bearish trend could also be influenced by broader market factors or investor sentiment towards the telemedicine sector, despite optimistic growth projections for the industry.

06.00.2026 - TDOC Stock was up 8.5%

• The participation of Teladoc Health's CEO in the 44th Annual J.P. Morgan Healthcare Conference likely boosted investor confidence in the company's future prospects and growth opportunities.
• The optimistic forecast for the "Online Doctor Consultations Market" and Teladoc Health's recognition as a key player in the sector might have influenced the bullish trend.
• Despite encountering obstacles in the post-pandemic market and facing doubts from financial analysts, Teladoc Health's endeavors to enhance profitability and broaden partnerships appear to be well-received by investors, propelling the stock upwards.
• In conclusion, the positive impact of the CEO's conference involvement, market growth predictions, and strategic measures to address past concerns possibly drove the bullish movement in Teladoc Health's stock.

06.01.2026 - TDOC Stock was up 5.1%

• Teladoc Health's strong bullish movement today could be attributed to the positive sentiment surrounding its efforts to enhance hypertension care through telemedicine services, showcasing its commitment to improving patient outcomes.
• The upcoming announcement of Teladoc Health's fourth-quarter 2025 financial results might have sparked investor optimism, leading to increased buying activity and driving the stock higher.
• Despite recent price drops and concerns about lacklustre performance, the market may be reacting positively to the potential growth opportunities in the digital therapeutics industry, where Teladoc Health plays a significant role.
• Jim Cramer's bearish outlook on Teladoc Health, citing reasons to sell the stock, could have initially caused some uncertainty; however, the market's response today indicates a divergence from this sentiment, potentially driven by a focus on the company's innovative healthcare solutions and future growth prospects.

11.01.2026 - TDOC Stock was down 9.2%

• Today's decline in TDOC's stock price could be attributed to profit-taking by investors following a period of increased bullish activity in the options market.
• Concerns about Teladoc's financial health, including negative ROE and financial distress indicators, may have contributed to the stock's downward pressure despite positive long-term growth prospects for the telemedicine industry.
• The market response may be tied to valuation metrics indicating that TDOC's stock is currently trading near historical lows for its price-to-sales and price-to-book ratios, prompting questions about its current valuation and potential future growth.
• Despite the overall positive outlook for the telehealth market and the innovation and growth driven by key players, individual company performance and financial metrics like those of Teladoc can still impact short-term stock movements.

05.01.2026 - TDOC Stock was down 5.6%

• Teladoc Health's stock faced a significant bearish trend today, which could have been influenced by:
• Negative remarks by Jim Cramer, suggesting investors to sell due to fierce competition in the virtual medical care industry and more lucrative opportunities in AI stocks.
• Substantial stock price declines in the last month and year, indicating diminished investor confidence and future growth prospects.
• Despite being listed as one of the 2021 TIME100 Most Influential Companies, concerns about Teladoc's future competitiveness in the telehealth sector might be impacting its stock performance.
• The perception shift of Teladoc as an infrastructure investment rather than a high-growth stock, potentially undermining investor faith in the company's ability to deliver swift returns.

03.01.2026 - TDOC Stock was down 8.5%

• Teladoc Health (TDOC) faced a strong bearish trend, declining 13.9% due to Medicare's decision to restrict telehealth coverage, particularly in rural areas and for specific mental health services. Concerns arose about decreasing BetterHelp users, rising competition, and the company's path to profitability.
• Despite being undervalued, regulatory uncertainties stemming from Medicare policy adjustments and potential impacts on earnings resulting from BetterHelp's revenue model transition are major factors influencing market skepticism and the decline in TDOC stock.
• Teladoc Health's CEO is prioritizing sustainable long-term growth and implementing strategic initiatives like broadening insurance acceptance for BetterHelp and targeted mergers and acquisitions to address some apprehensions. Nevertheless, investor sentiment remains dampened by the uncertainties surrounding reimbursement modifications and competitive dynamics.
• Today's notable bearish movement in Teladoc Health's stock can be attributed to a mix of regulatory hurdles, competitive pressures, and the necessity for clear implementation of growth strategies amidst market ambiguities.

18.10.2025 - TDOC Stock was up 5.2%

• TDOC's bullish movement today can be attributed to its accelerated global expansion efforts.
• The company's focus on expanding international operations and increasing overseas revenues is boosting its profitability outlook, which is likely driving investor confidence and pushing the stock price higher.
• The market is responding favorably to TDOC's strategic initiatives to tap into new markets and capitalize on the growing demand for telehealth services, positioning the company for long-term success in the evolving healthcare industry.

23.11.2025 - TDOC Stock was down 5.5%

• A financial institution initiated coverage on Teladoc with an Equal Weight rating and a price target of $8.50, reflecting a neutral outlook on the industry.
• Despite potential undervaluation according to certain analyses like the DCF model and a low Price to Sales ratio, mixed user growth metrics and possible competition in the telehealth market raised investor concerns, leading to a bearish trend.
• The announcement of a board director's retirement in 2026 raised questions about the company's future leadership and strategic direction, impacting the stock sentiment negatively.
• The filing for a potential issuance of $13.6 million in common stock for an employee stock ownership plan, along with a reassessment of the company's valuation, prompted investors to scrutinize further, contributing to the bearish movement in the stock.

14.00.2026 - TDOC Stock was down 5.3%

• Today's downward movement in TDOC stock may stem from profit-taking by investors following a period of strong growth. Teladoc Health recently garnered recognition as "Best in Business 2025" for its contributions to telehealth.
• Despite introducing new capabilities to treat a broader array of conditions and enhance care coordination, there are concerns in the market about the company's ability to maintain its competitive position in the evolving telemedicine landscape.
• Projections point to a bright long-term future for the telemedicine sector, estimated to reach $488.89 billion by 2033, indicating significant growth potential for companies like Teladoc Health. However, short-term market volatility and investor sentiment could influence stock performance in the near term.
• In conclusion, while Teladoc Health's strategic expansions and progress in virtual care services show promise, market conditions and investor expectations likely played a role in today's decline in TDOC stock.

27.00.2026 - TDOC Stock was down 5.1%

• Despite offering free non-emergency care to Texans affected by the recent winter storm, Teladoc Health (TDOC) experienced a strong bearish movement in the market.
• Investor caution and concerns about user trends and profitability have led to significant share price declines over the past year, even though the stock is trading at a notable discount to its intrinsic value and analyst targets.
• The company's recent upgrades to its 24/7 Care service, including expanded virtual urgent care and specialist input, have not been sufficient to offset the market's worries about future growth concerns and chronic care contracts.
• While Teladoc's data-driven expansion strategy aims to solidify its position in virtual care competition, challenges like weak user growth and ongoing losses continue to weigh on the stock's performance, leaving investors cautious about its long-term prospects.

20.10.2025 - TDOC Stock was up 5.1%

• The partnership with TytoCare to expand at-home exam capabilities indicates Teladoc Health's commitment to offering comprehensive virtual care solutions, which likely boosted investor confidence in the stock.
• Teladoc Health's efforts to accelerate global expansion and increase international operations have contributed to a positive outlook for the company's profitability, driving investor interest and pushing the stock price higher.
• The bullish movement in TDOC's stock can be attributed to the market's positive reception of the company's strategic initiatives to broaden its services and geographical presence, positioning it for sustained growth in the telemedicine sector.

07.00.2026 - TDOC Stock was down 5.0%

• Today's decline in TDOC's stock price may be linked to cautious investor sentiment surrounding concerns about competition, revenue diversification, and net losses affecting the company's valuation.
• The publication outlining reasons to steer clear of investing in Teladoc Health stock likely contributed to the negative sentiment among investors, prompting a selloff.
• The CEO of Teladoc Health is set to participate in the J.P. Morgan Healthcare Conference, where insights into the company's strategies for addressing current challenges are anticipated by investors.